Skip to main content
Ships fully reconstituted · no mixing, no powder, no bacteriostatic water
All peptides
Tesamorelin/Ipamorelin
Growth Hormone

Tesamorelin/Ipamorelin

Ships fully reconstituted · no mixing, no powder, no bacteriostatic water

Advanced Metabolic & GH Combo

Dual-pathway GH combo targeting visceral fat and lean body composition.

Choose your supply

Physician-reviewed · charged only after your prescription is approved
Free shipping over $350 · compounded in a U.S. pharmacy
Secure checkout · 256-bit encryption

Frequently paired with

What it supports

  • Targeted visceral fat reduction
  • Enhanced lean muscle mass
  • Improved metabolic function
  • Better sleep quality
  • Increased energy and recovery
  • Clean GH release profile
  • Supports healthy lipid levels

The details

Administration
Subcutaneous injection
Format
2mg/mL (Tesamorelin) + 1mg/mL (Ipamorelin), 5mL vial
Typical dosing
Per provider guidance, subcutaneous injection daily
Best for
Visceral fat reduction, body composition, lean mass
Pairs well with
MOTS-C, AOD 9604
Tesamorelin activates GHRH receptors for sustained GH release and targeted lipolysis, while Ipamorelin selectively triggers ghrelin-pathway GH secretion. Together they amplify fat-burning and muscle-sparing effects without cortisol or prolactin spikes.

How it works

Signal

Tesamorelin/Ipamorelin is given as a single daily subcutaneous injection on a provider-determined schedule.

Cellular response

Tesamorelin activates GHRH receptors for sustained GH release and targeted lipolysis in visceral fat, while Ipamorelin selectively triggers ghrelin-pathway GH secretion. Together they amplify fat-burning and muscle-sparing effects without cortisol or prolactin spikes.

Outcome

Over the following weeks most people notice better sleep and a small energy lift first (weeks 1–2), then a looser waistband and faster recovery (weeks 2–4), then measurable belly-fat reduction and visible body-composition change (weeks 4–8), with the strongest results from week 8 onward.

Research highlights

Tesamorelin FDA-approved for visceral fat reduction

Ipamorelin well-studied for selective GH release

Complementary mechanisms maximize body composition benefits

Strong safety profiles for both compounds

Research summaries are provided for educational context and are not a promise of results. Talk with your provider about what to expect.

Sources & references

  • Visceral fat reduction with Tesamorelin

    Falutz J et al. N Engl J Med. 2010;362(9):846–858.

    View source
  • Ipamorelin: selective GH release

    Raun K et al. Eur J Endocrinol. 1999;141(2):180–189.

    View source
  • Tesamorelin metabolic benefits over 12 months

    Stanley TL et al. J Clin Endocrinol Metab. 2012;97(3):983–991.

    View source

Common questions

Important safety information

Tesamorelin/Ipamorelin is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.

  • Generally well tolerated
  • Possible injection site reactions
  • Should not be used with active cancer
  • Requires licensed provider supervision